Pfizer to buy Wyeth for $68 billion

PHILADELPHIA/NEW YORK (Reuters) – Pfizer Inc said Monday it will acquire rival U.S. drugmaker Wyeth for $68 billion to soften the blow of losing its biggest product to generic competition, but a dividend cut and large debt financing concerned investors.

Leave a Reply